Lisa Suchower

768 total citations
19 papers, 613 citations indexed

About

Lisa Suchower is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Gastroenterology. According to data from OpenAlex, Lisa Suchower has authored 19 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Gastroenterology. Recurrent topics in Lisa Suchower's work include Helicobacter pylori-related gastroenterology studies (9 papers), Gastric Cancer Management and Outcomes (6 papers) and Gastroesophageal reflux and treatments (5 papers). Lisa Suchower is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (9 papers), Gastric Cancer Management and Outcomes (6 papers) and Gastroesophageal reflux and treatments (5 papers). Lisa Suchower collaborates with scholars based in United States, United Kingdom and Sweden. Lisa Suchower's co-authors include Hermann Haller, Ingrid Gause‐Nilsson, Ivan Rychlík, Mark Warren, Michał Nowicki, Garry A. Neil, Loren Laine, Jennifer Sugg, John F. Johanson and Loren Laine and has published in prestigious journals such as Gastroenterology, CHEST Journal and The American Journal of Gastroenterology.

In The Last Decade

Lisa Suchower

19 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lisa Suchower United States	12	403	240	187	145	86	19	613
H. G. Dammann Germany	16	461 1.1×	48 0.2×	351 1.9×	135 0.9×	81 0.9×	70	678
W Fuchs Germany	15	230 0.6×	126 0.5×	158 0.8×	75 0.5×	40 0.5×	28	442
Ishizaki Japan	4	235 0.6×	18 0.1×	215 1.1×	78 0.5×	68 0.8×	7	421
C. J. Gavey United Kingdom	10	295 0.7×	22 0.1×	216 1.2×	114 0.8×	28 0.3×	13	424
Rajendra P. Sarva United States	10	260 0.6×	47 0.2×	70 0.4×	200 1.4×	17 0.2×	11	542
Markus Goldschmiedt United States	11	266 0.7×	13 0.1×	153 0.8×	98 0.7×	66 0.8×	20	417
Marinko Marušić Croatia	7	133 0.3×	61 0.3×	70 0.4×	43 0.3×	10 0.1×	30	299
Alejandro Raddatz Chile	10	356 0.9×	103 0.4×	45 0.2×	142 1.0×	11 0.1×	14	536
J Linde Denmark	6	203 0.5×	51 0.2×	156 0.8×	74 0.5×	11 0.1×	11	341
B. G. Petersson Sweden	12	223 0.6×	87 0.4×	31 0.2×	34 0.2×	20 0.2×	18	453

Countries citing papers authored by Lisa Suchower

Since Specialization

Citations

This map shows the geographic impact of Lisa Suchower's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Suchower with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Suchower more than expected).

Fields of papers citing papers by Lisa Suchower

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Suchower. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Suchower. The network helps show where Lisa Suchower may publish in the future.

Co-authorship network of co-authors of Lisa Suchower

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Suchower. A scholar is included among the top collaborators of Lisa Suchower based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Suchower. Lisa Suchower is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Frías, Juan P., Lisa Suchower, L. E. B. Johansson, et al.. (2021). Long‐term effects of dapagliflozin plus saxagliptin versus glimepiride on a background of metformin in patients with type 2 diabetes: Results of a 104‐week extension to a 52‐week randomized, phase 3 study and liver fat MRI substudy. Diabetes Obesity and Metabolism. 24(1). 61–71. 7 indexed citations

Raalte, Daniël H. van, Cristian Guja, Klaas Hoogenberg, et al.. (2020). Exenatide once weekly decreases urinary albumin excretion in patients with type 2 diabetes and elevated albuminuria: Pooled analysis of randomized active controlled clinical trials. Diabetes Obesity and Metabolism. 22(9). 1556–1566. 23 indexed citations

Guja, Cristian, Juan P. Frías, Lisa Suchower, et al.. (2020). Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease. Diabetes Therapy. 11(7). 1467–1480. 5 indexed citations

Nowicki, Michał, Ivan Rychlík, Hermann Haller, et al.. (2011). Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study. International Journal of Clinical Practice. 65(12). 1230–1239. 108 indexed citations

Nowicki, Michał, Ivan Rychlík, Hermann Haller, et al.. (2011). Saxagliptin improves glycaemic control and is well tolerated in patients with type 2 diabetes mellitus and renal impairment. Diabetes Obesity and Metabolism. 13(6). 523–532. 105 indexed citations

Laties, Alan M., Stephen I. Rennard, Donald P. Tashkin, Lisa Suchower, & Ubaldo J. Martin. (2010). Effect of Budesonide/Formoterol Pressurized Metered-Dose Inhaler (BUD/FM pMDI) on Ophthalmologic Assessments in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) Patients: Results From a 1-Year, Randomized, Controlled Clinical Trial. CHEST Journal. 138(4). 468A–468A. 4 indexed citations

Rennard, Stephen I., Donald P. Tashkin, Lisa Suchower, & Ubaldo J. Martin. (2010). Effect of Budesonide/Formoterol Pressurized Metered-Dose Inhaler (BUD/FM pMDI) on Bone Mineral Density (BMD) in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) Patients: Results From a 1-Year, Randomized, Controlled Clinical Trial. CHEST Journal. 138(4). 863A–863A. 4 indexed citations

Goldstein, Jay L., John F. Johanson, Christopher J. Hawkey, Lisa Suchower, & Kurt Brown. (2007). Clinical trial: healing of NSAID‐associated gastric ulcers in patients continuing NSAID therapy – a randomized study comparing ranitidine with esomeprazole. Alimentary Pharmacology & Therapeutics. 26(8). 1101–1111. 40 indexed citations

Goldstein, Jay L., John F. Johanson, Lisa Suchower, & Kurt Brown. (2005). Healing of Gastric Ulcers with Esomeprazole Versus Ranitidine in Patients Who Continued to Receive NSAID Therapy: A Randomized Trial. The American Journal of Gastroenterology. 100(12). 2650–2657. 40 indexed citations

10.

Laine, Loren, Brian Fennerty, Michael S. Osato, et al.. (2000). Esomeprazole-Based Helicobacter Pylori Eradication Therapy and The Effect of Antibiotic Resistance: Results of Three Us Multicenter, Double-Blind Trials. The American Journal of Gastroenterology. 95(12). 3393–3398. 117 indexed citations

11.

Laine, Loren, Jennifer Sugg, Lisa Suchower, & Garry A. Neil. (2000). Endoscopic biopsy requirements for post-treatment diagnosis of Helicobacter pylori. Gastrointestinal Endoscopy. 51(6). 664–669. 20 indexed citations

12.

Laine, Loren, M. Brian Fennerty, Lisa Suchower, et al.. (2000). H. pylori antibiotic resistance, eradication, and emergent resistance in U.S. double-blind trials of esomeprazole, clarithromycin, and amoxicillin. Gastroenterology. 118(4). A498–A498. 1 indexed citations

13.

Laine, Loren, et al.. (1998). Low rate of emergence of clarithromycin‐resistant Helicobacter pylori with amoxycillin co‐therapy. Alimentary Pharmacology & Therapeutics. 12(9). 887–892. 20 indexed citations

14.

Laine, Loren, et al.. (1998). Accuracy of CLOtest after Helicobacter pylori therapy. Gastrointestinal Endoscopy. 47(3). 250–253. 18 indexed citations

15.

Laine, Loren, Lisa Suchower, Jonathan M. Frantz, Alfred F. Connors, & Garry A. Neil. (1998). Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials. The American Journal of Gastroenterology. 93(11). 2106–2112. 48 indexed citations

16.

Laine, Loren, et al.. (1998). Twice-daily 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for H. Pylori eradication in duodenal ulcer disease: Results of 3 multicenter, double-blind, U.S. Trials. Gastroenterology. 114. A193–A193. 6 indexed citations

17.

Neil, Garry A., et al.. (1997). Time of Helicobacter pylori Eradication Assessment Following Treatment. Helicobacter. 2(1). 13–20. 23 indexed citations

18.

Brahim, Jaime S., et al.. (1994). Comparison of single-dose ibuprofen lysine, acetylsalicylic acid, and placebo for moderate-to-severe postoperative dental pain.. PubMed. 16(3). 458–65. 19 indexed citations

19.

Bradstreet, Thomas E., Rayanne S. Berman, Margaret D. Copenhaver, et al.. (1992). A Statistics Appreciation Course for Clinical Research Personnel. Drug Information Journal. 26(1). 31–40. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact